HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Engrafted human induced pluripotent stem cell-derived anterior specified neural progenitors protect the rat crushed optic nerve.

AbstractBACKGROUND:
Degeneration of retinal ganglion cells (RGCs) is a common occurrence in several eye diseases. This study examined the functional improvement and protection of host RGCs in addition to the survival, integration and neuronal differentiation capabilities of anterior specified neural progenitors (NPs) following intravitreal transplantation.
METHODOLOGY/PRINCIPAL FINDINGS:
NPs were produced under defined conditions from human induced pluripotent stem cells (hiPSCs) and transplanted into rats whose optic nerves have been crushed (ONC). hiPSCs were induced to differentiate into anterior specified NPs by the use of Noggin and retinoic acid. The hiPSC-NPs were labeled by green fluorescent protein or a fluorescent tracer 1,1' -dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiI) and injected two days after induction of ONC in hooded rats. Functional analysis according to visual evoked potential recordings showed significant amplitude recovery in animals transplanted with hiPSC-NPs. Retrograde labeling by an intra-collicular DiI injection showed significantly higher numbers of RGCs and spared axons in ONC rats treated with hiPSC-NPs or their conditioned medium (CM). The analysis of CM of hiPSC-NPs showed the secretion of ciliary neurotrophic factor, basic fibroblast growth factor, and insulin-like growth factor. Optic nerve of cell transplanted groups also had increased GAP43 immunoreactivity and myelin staining by FluoroMyelin™ which imply for protection of axons and myelin. At 60 days post-transplantation hiPSC-NPs were integrated into the ganglion cell layer of the retina and expressed neuronal markers.
CONCLUSIONS/SIGNIFICANCE:
The transplantation of anterior specified NPs may improve optic nerve injury through neuroprotection and differentiation into neuronal lineages. These NPs possibly provide a promising new therapeutic approach for traumatic optic nerve injuries and loss of RGCs caused by other diseases.
AuthorsLeila Satarian, Mohammad Javan, Sahar Kiani, Maryam Hajikaram, Javad Mirnajafi-Zadeh, Hossein Baharvand
JournalPloS one (PLoS One) Vol. 8 Issue 8 Pg. e71855 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID23977164 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Culture Media, Conditioned
  • Nerve Growth Factors
Topics
  • Animals
  • Cell Differentiation
  • Cell Movement
  • Cell Survival
  • Cells, Cultured
  • Culture Media, Conditioned
  • Cytoprotection
  • Evoked Potentials, Visual
  • Humans
  • Induced Pluripotent Stem Cells (physiology)
  • Male
  • Nerve Growth Factors (metabolism)
  • Nerve Regeneration
  • Neural Stem Cells (physiology, transplantation)
  • Optic Nerve (pathology, physiopathology)
  • Optic Nerve Injuries (physiopathology, therapy)
  • Rats
  • Retinal Ganglion Cells (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: